Want to join the conversation?
$HSP Hospira Inc., the prominent provider of injectable drugs & infusion technologies was acquired by Pfizer Inc today. Pfizer anticipates the transaction to be accretive right away to adjusted diluted EPS upon closing, and accretive by $0.10-0.12 per share in the first full year after the close, with further accretion expected thenceforth.
Apple ($AAPL) reported decline in sales and profits from comparable quarter last year, attributing the decline to announcement of iPhone 7/7s. Sales and profit are being guided higher for next quarter. Apple is a solid company and will continue to dominate tech and consumer electronics segment for a while. Personally, looks like there is little downside in this investment.
Waiting with fingers crossed for $AAPL’s fourth quarter earnings.
Looking ahead to $AAPL earnings release later in the afternoon today? Gene Munster, analyst from Piper Jaffrey and the most respected authority for Apple, had this to say - "The second and slightly larger group of investors believe the tail of the iPhone 7 is irrelevant, and is betting that the iPhone 10th Anniversary will yield a jump in growth from flat to up ~15%."